Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer.
暂无分享,去创建一个
Roberto Passariello | Valeria Panebianco | Alessandro Sciarra | Marcello Osimani | Vincenzo Gentile | R. Passariello | V. Panebianco | A. Sciarra | V. Gentile | Mauro Ciccariello | Stefano Salciccia | Danilo Lisi | Franco Di Silverio | S. Salciccia | F. di Silverio | M. Osimani | M. Ciccariello | D. Lisi
[1] D. Weckermann,et al. Prostate Cancer Relapse after Therapy with Curative Intention: A Diagnostic and Therapeutic Dilemma , 2005, Oncology Research and Treatment.
[2] D. Kuban,et al. Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial. , 2002, International journal of radiation oncology, biology, physics.
[3] D. Chan,et al. Natural History of Progression After PSA Elevation Following Radical Prostatectomy , 1999 .
[4] C. Abbou,et al. EAU guidelines on prostate cancer. , 2009, European urology.
[5] P. Karakiewicz,et al. Prostate cancer-specific survival in men treated with hormonal therapy after failure of radical prostatectomy. , 2007, European urology.
[6] Michel Rouzaud,et al. Endorectal MRI assessment of local relapse after surgery for prostate cancer: A model to define treatment field guidelines for adjuvant radiotherapy in patients at high risk for local failure. , 2007, International journal of radiation oncology, biology, physics.
[7] E. Bergstralh,et al. Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point? , 2001, The Journal of urology.
[8] M. Zerbib,et al. Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study. , 2005, European urology.
[9] D. Grignon,et al. Vesicourethral anastomosis biopsy after radical prostatectomy: predictive value of prostate-specific antigen and pathologic stage. , 1999, Urology.
[10] R. Passariello,et al. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. , 2008, European urology.
[11] Dennis W J Klomp,et al. Initial Experience of 3 Tesla Endorectal Coil Magnetic Resonance Imaging and 1H-Spectroscopic Imaging of the Prostate , 2004, Investigative radiology.
[12] Chinyere N. Onyebuchi,et al. Advances in imaging in the postoperative patient with a rising prostate-specific antigen level. , 2003, Seminars in oncology.
[13] A. Skolarikos,et al. Diagnostic efficacy of transrectal ultrasound-guided biopsy of the prostatic fossa in patients with rising PSA following radical prostatectomy , 2007, World Journal of Urology.
[14] A. Aschoff,et al. Sensitivity of computed tomography in detecting local recurrence of prostatic carcinoma following radical prostatectomy. , 1997, The British journal of radiology.
[15] M. Soloway,et al. Failure after radical prostatectomy. , 2003, Urology.
[16] Alan W Partin,et al. Clinical utility of indium 111‐capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomy , 2002, Cancer.
[17] J. Kurhanewicz,et al. Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience. , 2005, Radiology.
[18] J. Silverman,et al. MR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy. , 1997, AJR. American journal of roentgenology.
[19] H. Hricak,et al. Preliminary assessment of magnetic resonance spectroscopic imaging in predicting treatment outcome in patients with prostate cancer at high risk for relapse. , 2004, Clinical prostate cancer.
[20] S. Shariat,et al. Local recurrence after radical prostatectomy: correlation of US features with prostatic fossa biopsy findings. , 2001, Radiology.
[21] W. Catalona,et al. Primary treatment choices for men with clinically localized prostate carcinoma detected by screening , 2000, Cancer.
[22] K. Shinohara,et al. Transrectal ultrasound guided prostatic nerve blockade eases systematic needle biopsy of the prostate. , 1996, The Journal of urology.
[23] Clare Allen,et al. How good is MRI at detecting and characterising cancer within the prostate? , 2006, European urology.
[24] T. Hara,et al. PET imaging of prostate cancer using carbon-11-choline. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[25] P. Carroll,et al. Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins. , 1996, Urology.
[26] F. Fazio,et al. Diagnosis of local recurrence after radical prostatectomy , 2004, BJU international.
[27] R. Huben,et al. The use of transrectal ultrasound in the detection and evaluation of local pelvic recurrences after a radical urological pelvic operation. , 1990, The Journal of urology.
[28] M Bolla,et al. EAU guidelines on prostate cancer. , 2001, European urology.
[29] P. Carroll,et al. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. , 1996, Radiology.
[30] Peter L Choyke,et al. Imaging prostate cancer: a multidisciplinary perspective. , 2007, Radiology.
[31] K. Badani,et al. Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostastic biopsy: a pilot study. , 2000, The Journal of urology.
[32] J. Forman,et al. THERAPEUTIC IRRADIATION FOR PATIENTS WITH AN ELEVATED POST-PROSTATECTOMY PROSTATE SPECIFIC ANTIGEN LEVEL , 1997 .
[33] Heinz-Peter Schlemmer,et al. MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies. , 2006, European urology.
[34] M. D. Saleem,et al. Factors predicting cancer detection in biopsy of the prostatic fossa after radical prostatectomy. , 1998, Urology.
[35] K. Harada,et al. Usefulness of the Nadir Value of Serum Prostate-Specific Antigen Measured by an Ultrasensitive Assay as a Predictor of Biochemical Recurrence after Radical Prostatectomy for Clinically Localized Prostate Cancer , 2006, Urologia Internationalis.
[36] E. Messing,et al. Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] H. Huisman,et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. , 2006, Radiology.
[38] S. Freedland,et al. Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Prostate-specific antigen. , 2003, Urology.